Agilent Technologies, Inc. has completed the acquisition of Lausanne, Switzerland-based Genohm, a developer of highly di...
Organogenesis has announced that Gary S. Gillheeney, Sr., President and CEO of Organogenesis Inc., has been appointed to...
Discngine, a software company specialized in developing applications for life sciences research, has received funding of...
Emergex Vaccines Holding Limited (‘Emergex’), a biotechnology company pioneering a new approach to vaccine d...
Eli Lilly and Co said on Thursday it is willing to buy Armo BioSciences Inc, for US$1.6 billion, an offer of US$50 per s...
U.S. regulators said on Wednesday that Mylan NV's EpiPen products are in shortage due to manufacturing delays that are c...
Researchers from NYU School of Medicine have developed a glove-shaped magnetic resonance imaging (MRI) detector that can...
Openwater is a healthcare company that is revolutionizing and minitiarizing the way we read and write our body and brain...
The first vaccine campaign against cholera in Yemen has been started by the World Health Organization (WHO), a year and ...
Singapore– Pfizer has selected the final two targets in a two-year-old, up-to-$911 million collaboration with...
Singapore– ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both ...
Kindred Biosciences, Inc. a biopharmaceutical company focused on saving and improving the lives of pets, announced that ...
Researchers from the KTH Royal Institute of Technology in Stockholm, Sweden, have developed an adhesive that could help ...
Singapore- Inspire Medical Systems, which sells an implanted device for treating obstructive sleep apnea, raised $108 mi...
Singapore- Paradigm is pleased to announce the publication of an article titled "Performance of next-generation sequenci...
Singapore- Dublin, Ireland-domiciled Iterum Therapeutics (ITRM) has filed a preliminary prospectus f...
Singapore- Agilent Technologies announced that it has entered into a definitive agreement to acquire privately-held Geno...
The Wyss Institute for Biologically Inspired Engineering at Harvard University and Cellectis, a clinical-stage biopharma...
